Fluorescence Localization of Tight Junction Proteins and Stress Fibers in Endothelial Cells
JoVE Encyclopedia of Experiments
Neuroscience
0 views • 4:15 min • April 28th, 2025
Take a chambered slide containing a monolayer culture of rat brain microvascular endothelial cells, or RBMECs, mimicking the endothelial cell layer of the blood-brain barrier.
The cells exhibit disrupted tight junction proteins and actin stress fibers due to stress from oxygen-glucose deprivation followed by reoxygenation.
Remove the medium and wash the cells, apply a fixative to preserve cell architecture, then wash off excess fixative.
Treat with a detergent to permeabilize cellular membranes.
Incubate with a blocking agent to mask non-specific binding sites.
To label tight junction proteins, incubate with specific primary antibodies, then remove unbound antibodies.
Incubate with fluorophore-conjugated secondary antibodies to label the primary antibodies.
Alternatively, to label the stress fibers, add fluorophore-tagged phalloidin.
Wash to remove unbound labeling molecules.
Remove the chamber, apply a mounting medium containing a fluorescent DNA-binding dye to stain nuclei, then seal with a coverslip.
Using confocal microscopy, visualize the fluorescently labeled tight junction proteins and stress fibers.
Begin with exposing each well of RBMEC monolayers to 100 to 200 microliters of Opti-MEM reduced serum media, and continue their incubation for an hour. Then wash the chamber slides three times, using 100 to 200 microliters of PBS per well per wash. Fix the cells with 4% paraformaldehyde in PBS, and incubate the slides for 15 minutes at room temperature. And wash the cells off three times with PBS as before.
Now, permeabilize the cells by applying 100 to 200 microliters of 0.5% Triton X-100 in PBS to each well. And let the plate incubate for another 15 minutes at room temperature. After the cells have been permeabilized, apply the blocking solution. And let this act on the cells for an hour at room temperature.
Next, either perform immunofluorescence for ZO-1 protein or label F-actin. To conduct immunofluorescence of the cells for ZO-1, incubate them with the primary antibody overnight at 4 degrees Celsius. The next day, wash the cells three times in PBS, such as when removing the fixative. Then incubate the cells in 100 to 200 microliters of FITC tag anti-rabbit secondary antibody for an hour at room temperature, to label the cells with rhodamine phalloidin.
After applying the blocking solution for an hour, expose the cells to 100 to 200 microliters of rhodamine phalloidin in a 1 to 50 dilution, with 2% BSA PBS for 20 minutes. After the secondary antibody or rhodamine phalloidin incubation, wash the cells with PBS three times again as before. Then remove the chambers by peeling off the elastic. Proceed with mounting the slides, using medium containing antifade and DAPI. Image the cells with confocal microscopy in a single plane with a 60x objective.
Overview
This article describes a method for visualizing tight junction proteins and actin stress fibers in rat brain microvascular endothelial cells (RBMECs) under conditions of oxygen-glucose deprivation. The protocol includes cell fixation, permeabilization, and immunofluorescence labeling, followed by confocal microscopy imaging.
Key Study Components
Area of Science
- Neuroscience
- Cell Biology
- Immunofluorescence
Background
- RBMECs are crucial for studying the blood-brain barrier.
- Disruption of tight junctions can affect barrier integrity.
- Oxygen-glucose deprivation is a model for studying ischemic conditions.
- Immunofluorescence allows for the visualization of specific proteins.
Purpose of Study
- To investigate the effects of oxygen-glucose deprivation on RBMECs.
- To visualize tight junction proteins and actin stress fibers.
- To provide a detailed protocol for researchers studying the blood-brain barrier.
Methods Used
- Culture of RBMECs in chambered slides.
- Fixation with paraformaldehyde and permeabilization with Triton X-100.
- Blocking non-specific binding sites before antibody incubation.
- Immunofluorescence labeling with primary and secondary antibodies.
Main Results
- Successful visualization of tight junction proteins ZO-1.
- Labeling of actin stress fibers using rhodamine phalloidin.
- Confocal microscopy provided clear images of cellular structures.
- Demonstrated the impact of oxygen-glucose deprivation on RBMECs.
Conclusions
- The protocol effectively visualizes key components of RBMECs.
- Findings contribute to understanding blood-brain barrier dynamics.
- Can be applied to further studies on ischemic conditions.
Frequently Asked Questions
Executive Industry Relevance
This method enables visualization of tight junction integrity and cytoskeletal reorganization in endothelial models of the blood-brain barrier under ischemic stress. It supports mechanistic de-risking of neurovascular targets by providing quantitative imaging of barrier dysfunction. The approach aids in early target validation and phenotypic screening for cerebrovascular drug discovery programs.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of blood-brain barrier permeability mechanisms through direct imaging of tight junction protein localization.
- Operational Value: Provides a standardized immunofluorescence workflow for assessing endothelial barrier integrity in vitro.
Screening & Assay Development
- Scientific Value: Generates quantitative confocal readouts of ZO-1 disruption and actin stress fiber formation as functional biomarkers of barrier compromise.
- Operational Value: Delivers reproducible, imaging-based endpoints suitable for high-content screening of vasoactive compounds.
Translational & Preclinical Research
- Scientific Value: Models oxygen-glucose deprivation-reoxygenation to simulate ischemic reperfusion injury relevant to stroke pathophysiology.
- Operational Value: Supports continuity from mechanistic discovery to preclinical validation of neuroprotective candidates targeting the neurovascular unit.
Pipeline & Workflow Integration
The method fits within the discovery continuum from target hypothesis testing to lead optimization, particularly for CNS-penetrant molecules requiring blood-brain barrier penetration assessment.
- Discovery Biology: Facilitates mechanistic interrogation of endothelial stress responses and junctional complex stability under ischemic conditions.
- Screening: Enables assay-ready endothelial monolayers with quantifiable immunofluorescence outputs for compound effect evaluation.
- Analytics: Provides confocal-derived intensity and localization metrics for tight junction proteins and actin cytoskeleton as quantitative readouts.
- Translational Research: Links in vitro barrier dysfunction models to preclinical stroke pathology through conserved endothelial stress signatures.
- Enterprise Reuse: Establishes a reusable immunofluorescence platform for blood-brain barrier modeling across multiple discovery projects.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation by reducing ambiguity in endothelial mechanism of action.
- Operational Value: Enhances reproducibility and standardization of barrier integrity assessments across teams and sites.
- Strategic Value: Improves go/no-go decision quality by enabling early detection of neurovascular liability signals.
- Portfolio Impact: Supports risk-adjusted prioritization of CNS drug candidates based on blood-brain barrier interaction profiles.
Implementation Considerations
- Requires expertise in immunofluorescence staining, confocal microscopy, and endothelial cell culture.
- Dependent on access to fluorescence microscopes with confocal capabilities and appropriate antibody reagents.
- Necessitates standardization of fixation, permeabilization, and blocking steps across experimental batches.
- Involves adaptation considerations when translating from rat brain microvascular endothelial cells to human or iPSC-derived models.
- Includes practical limitations such as antibody specificity dependence and photobleaching risks during imaging.
Biopharma FAQs
Measuring Protein Binding to F-actin by Co-sedimentation
Related Videos
0 Views
In Vitro Polymerization of F-actin on Early Endosomes
Related Videos
0 Views
Functional Assessment of Intestinal Tight Junction Barrier and Ion Permeability in Native Tissue by Ussing Chamber Technique
Related Videos
0 Views
Study of the Actin Cytoskeleton in Live Endothelial Cells Expressing GFP-Actin
Related Videos
0 Views
Cytoskeleton and Focal Adhesion Organization Assay: An Immunofluorescence-based Method to Study Cell Adhesion and Spreading on Substrates
Related Videos
0 Views
Visualization of Endoplasmic Reticulum Subdomains in Cultured Cells
Related Videos
0 Views
Long-term Intravital Immunofluorescence Imaging of Tissue Matrix Components with Epifluorescence and Two-photon Microscopy
Related Videos
0 Views
Real-time Imaging of Endothelial Cell-cell Junctions During Neutrophil Transmigration Under Physiological Flow
Related Videos
0 Views
Imaging Integrin Tension and Cellular Force at Submicron Resolution with an Integrative Tension Sensor
Related Videos
0 Views
Examining the Dynamics of Cellular Adhesion and Spreading of Epithelial Cells on Fibronectin During Oxidative Stress
Related Videos
0 Views
Last updated: 29 August 2026